Publication | Closed Access

Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable hepatocellular carcinoma: comparison with dual-tracer 18F-FDG and 18F-FCH PET/CT

Imaging BiomarkersAggressive FeaturesEngineeringPathologyOncologyHepatobiliary Tumor18F-fch Pet/ctMolecular ImagingNuclear MedicineRadiologyMedical ImagingHistopathologyReduced Recurrence-free SurvivalContrast AgentTumor MicroenvironmentHepatologyLiver CancerMedicineHepatocellular Carcinoma